IDH-mutant glioma cells reduce α-ketoglutarate to D2HG, which is structurally similar to glutamate and may mimic the activity of glutamate on NMDA receptors, potentially leading to seizures (25). This evidence concerns the gene IDH2 and central nervous system cancer.